DJIA 17,556.77 -41.43 -0.24%
NASDAQ 5,111.62 -3.77 -0.07%
S&P 500 2,095.89 -2.15 -0.10%
market minute promo

The Medicines Company (NASDAQ: MDCO)



company name or ticker

The Medicines Co. Antiplatelet Drug Kengreal Wins FDA Nod - Analyst Blog

Eagle Pharma Has 'Several Upcoming Catalysts' And Is A Buy, RBC Says

The Medicines Company Announces FDA Approval of KENGREAL as an Adjunct to Percutaneous Coronary Inte

The Medicines Company Announces FDA Approval of KENGREAL as an Adjunct to Percutaneous Coronary Intervention for Reducing Thrombotic Events

Insider Trading Alert - CLCT, MDCO And LQ Traded By Insiders

3 Surprising Biotech Stocks That Are Surging Higher

Here's what you need to know about these three soaring biotech stocks.

Who's The Next Big Pharma Acquisition?

Alnylam's Q1 Loss Narrower than Expected, Confirms Guidance - Analyst Blog

Alnylam Pharmaceuticals, Inc.'s Five-Year Plan

The biotech updated investors on its Alnylam 2020 plan during its first-quarter earnings announcement.

The Medicines Co. Incurs Loss in Q1, Angiomax Sales Fall - Analyst Blog

The Medicines (MDCO) Clive A. Meanwell on Q1 2015 Results - Earnings Call Transcript

See More Articles...